- Title
- GOG 8035: Nuclear BRCA1 loss may identify a poor prognostic subgroup of women with locally advanced cervical cancer treated with cisplatin-based chemoradiation: An NRG Oncology study
- Creators
- T.C. Longoria - University of California, Irvine Medical CenterM. Sill - Gynecologic Oncology GroupB.J. Monk - University of ArizonaJ. Fruehauf - University of California, IrvineS.Y. Liao - St. Joseph's Hospital and Medical CenterR. Emerson - Indiana UniversityJ.H. Kim - University of California, Irvine Medical CenterR.S. Mannel - University of Oklahoma Health Sciences CenterY.C. Lee - SUNY Downstate, Brooklyn, NY, USAC.A. Mathews - Women & Infants Hospital of Rhode IslandL.M. Randall - University of California at Irvine Medical Center, Orange, CA, USAK.M. Darcy - Walter Reed National Military Medical CenterM.J. Birrer - Massachusetts General HospitalK.S. Tewari - University of California, Irvine Medical Center
- Publication Details
- Gynecologic oncology, Vol.149, pp.37-38
- Publisher
- Elsevier Inc
- Identifiers
- 991005968887302656
- Academic Unit
- Obstetrics & Gynecology
- Language
- English
- Resource Type
- Journal article
Journal article
GOG 8035: Nuclear BRCA1 loss may identify a poor prognostic subgroup of women with locally advanced cervical cancer treated with cisplatin-based chemoradiation: An NRG Oncology study
Gynecologic oncology, Vol.149, pp.37-38
06/2018
Metrics
1 Record Views